An evalation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone

An evalation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BIERMANN, W. A, CANTOR, R. I, FELLIN, F. M, JAKOBOWSKI, J, HOPKINS, L, NEWBOLD, R. C
Format: Tagungsbericht
Sprache:eng
Schlagworte:
Antineoplastic agents
Biological and medical sciences
Chemotherapy
Medical sciences
Pharmacology. Drug treatments
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S42
container_issue
container_start_page S37
container_title
container_volume 12
creator BIERMANN, W. A
CANTOR, R. I
FELLIN, F. M
JAKOBOWSKI, J
HOPKINS, L
NEWBOLD, R. C
description
format Conference Proceeding
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_5034821</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>5034821</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_50348213</originalsourceid><addsrcrecordid>eNqNjcFOwzAMQKMJpJWxf_CBa6W2YWt3RAjEB3CfvMyFoCSuYheJz-CPSSe4c7Kl9-y3MlU79Lbu-r29MtXQ7_a17YZubW5EPpqmsYe-rcz3QwL6xIDqOQGPoO8EEysl9RjAsShkOs9u4VJWmYP69AZj5niRZ6HlzgU-Z06oBD5dgGZCjeXRgiMpipaKA4fZ-cQR_3KnIpaMMpw40a25HjEIbX_nxtw9P70-vtQTisMwZkzOy3HKPmL-Ou4aez90rf2n9gOxolpd</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype></control><display><type>conference_proceeding</type><title>An evalation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone</title><source>Elsevier ScienceDirect Journals Complete</source><creator>BIERMANN, W. A ; CANTOR, R. I ; FELLIN, F. M ; JAKOBOWSKI, J ; HOPKINS, L ; NEWBOLD, R. C</creator><creatorcontrib>BIERMANN, W. A ; CANTOR, R. I ; FELLIN, F. M ; JAKOBOWSKI, J ; HOPKINS, L ; NEWBOLD, R. C</creatorcontrib><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Bone (New York, NY), 1991, Vol.12, p.S37-S42</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,776,780,785,786,4036,4037,23909,23910,25118</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5034821$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>BIERMANN, W. A</creatorcontrib><creatorcontrib>CANTOR, R. I</creatorcontrib><creatorcontrib>FELLIN, F. M</creatorcontrib><creatorcontrib>JAKOBOWSKI, J</creatorcontrib><creatorcontrib>HOPKINS, L</creatorcontrib><creatorcontrib>NEWBOLD, R. C</creatorcontrib><title>An evalation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone</title><title>Bone (New York, NY)</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>1991</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNqNjcFOwzAMQKMJpJWxf_CBa6W2YWt3RAjEB3CfvMyFoCSuYheJz-CPSSe4c7Kl9-y3MlU79Lbu-r29MtXQ7_a17YZubW5EPpqmsYe-rcz3QwL6xIDqOQGPoO8EEysl9RjAsShkOs9u4VJWmYP69AZj5niRZ6HlzgU-Z06oBD5dgGZCjeXRgiMpipaKA4fZ-cQR_3KnIpaMMpw40a25HjEIbX_nxtw9P70-vtQTisMwZkzOy3HKPmL-Ou4aez90rf2n9gOxolpd</recordid><startdate>1991</startdate><enddate>1991</enddate><creator>BIERMANN, W. A</creator><creator>CANTOR, R. I</creator><creator>FELLIN, F. M</creator><creator>JAKOBOWSKI, J</creator><creator>HOPKINS, L</creator><creator>NEWBOLD, R. C</creator><general>Elsevier Science</general><scope>IQODW</scope></search><sort><creationdate>1991</creationdate><title>An evalation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone</title><author>BIERMANN, W. A ; CANTOR, R. I ; FELLIN, F. M ; JAKOBOWSKI, J ; HOPKINS, L ; NEWBOLD, R. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_50348213</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BIERMANN, W. A</creatorcontrib><creatorcontrib>CANTOR, R. I</creatorcontrib><creatorcontrib>FELLIN, F. M</creatorcontrib><creatorcontrib>JAKOBOWSKI, J</creatorcontrib><creatorcontrib>HOPKINS, L</creatorcontrib><creatorcontrib>NEWBOLD, R. C</creatorcontrib><collection>Pascal-Francis</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BIERMANN, W. A</au><au>CANTOR, R. I</au><au>FELLIN, F. M</au><au>JAKOBOWSKI, J</au><au>HOPKINS, L</au><au>NEWBOLD, R. C</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>An evalation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone</atitle><btitle>Bone (New York, NY)</btitle><date>1991</date><risdate>1991</risdate><volume>12</volume><spage>S37</spage><epage>S42</epage><pages>S37-S42</pages><issn>8756-3282</issn><eissn>1873-2763</eissn><cop>New York, NY</cop><pub>Elsevier Science</pub></addata></record>
fulltext fulltext
identifier ISSN: 8756-3282
ispartof Bone (New York, NY), 1991, Vol.12, p.S37-S42
issn 8756-3282
1873-2763
language eng
recordid cdi_pascalfrancis_primary_5034821
source Elsevier ScienceDirect Journals Complete
subjects Antineoplastic agents
Biological and medical sciences
Chemotherapy
Medical sciences
Pharmacology. Drug treatments
title An evalation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A27%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=An%20evalation%20of%20the%20potential%20cost%20reductions%20resulting%20from%20the%20use%20of%20clodronate%20in%20the%20treatment%20of%20metastatic%20carcinoma%20of%20the%20breast%20to%20bone&rft.btitle=Bone%20(New%20York,%20NY)&rft.au=BIERMANN,%20W.%20A&rft.date=1991&rft.volume=12&rft.spage=S37&rft.epage=S42&rft.pages=S37-S42&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E5034821%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true